Equities

PZ Cormay SA

CRM:WSE

PZ Cormay SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)0.478
  • Today's Change-0.002 / -0.42%
  • Shares traded75.41k
  • 1 Year change-16.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments101531
Total Receivables, Net131714
Total Inventory242719
Prepaid expenses------
Other current assets, total0.640.370.30
Total current assets475963
Property, plant & equipment, net242119
Goodwill, net------
Intangibles, net222116
Long term investments------
Note receivable - long term0.050.050.05
Other long term assets------
Total assets94102100
LIABILITIES
Accounts payable141810
Accrued expenses2.782.102.96
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.281.211.27
Other current liabilities, total151515
Total current liabilities333630
Total long term debt3.642.862.82
Total debt4.914.074.09
Deferred income tax0.870.710.55
Minority interest0.410.500.85
Other liabilities, total0.950.831.04
Total liabilities394135
SHAREHOLDERS EQUITY
Common stock848484
Additional paid-in capital939393
Retained earnings (accumulated deficit)(128)(123)(116)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total6.337.444.11
Total equity556165
Total liabilities & shareholders' equity94102100
Total common shares outstanding848484
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.